The 2nd Saudi Multiple Sclerosis Chapter Conference, hosted by the Multiple Sclerosis Chapter of the Saudi Neurology Society, is a premier gathering of healthcare professionals, researchers, and advocates in the field of neurology and multiple sclerosis (MS). Scheduled for April 10-11, 2026, at the Hilton Jeddah, Kingdom of Saudi Arabia, this conference builds upon the success of the inaugural event.
The conference serves as a platform for high-level discussions surrounding the latest advancements in MS research, treatment, and management. It features a scientific poster exhibition showcasing cutting-edge studies and innovative papers at the forefront of scientific inquiry. Participants will have the opportunity to present findings, share insights, and foster collaborative dialogue.
The event brings together distinguished faculty including leading neurologists and neuroimmunologists from Saudi Arabia, the GCC, and internationally. Topics covered include MS diagnosis, treatment strategies, emerging therapies, pediatric MS, and neuroimmunology advances. Registration categories include healthcare professionals (300 SAR) and students/residents/nurses (100 SAR). The conference is organized by Tawasol Events Hub and sponsored by major pharmaceutical companies including Roche, Novartis, Merck, Biogen, and Sanofi.
